Abstract
Voxelotor (Oxbryta (TM)) is a haemoglobin S polymerization inhibitor that has been developed for the treatment of sickle cell disease. In November 201......
小提示：本篇文献需要登录阅读全文，点击跳转登录
Full Text Link
